Journal of Pharmacology and Experimental Therapeutics

SJR Rank #5,578H-index: 254SJR: 0.921Best quartile: Q2APC: US$3,750
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Molecular MedicineQ2
  • PharmacologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal PhysiologyIon channel regulation and functionDiverse Scientific and Economic StudiesPharmacological Receptor Mechanisms and EffectsPain Mechanisms and TreatmentsNitric Oxide and Endothelin EffectsEicosanoids and Hypertension Pharmacology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025075150225300

Detailed Information

ISSN

1521-0103, 0022-3565

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

3.40

References per Document

59.31

Coverage

1943, 1945-2026

Scope

A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.

Metrics from SCImago Journal Rank 2025. View on SCImago